Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ACAD

ACADIA PHARMACEUTICALS INC

Pharmaceutical Preparations · SIC 2834CIK 1070494Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$1.07B
Net Income FY2025
$0.39B
EPS (Basic, as reported)
$2.32
Net Margin FY2025
36.5%
ROE FY2025
31.9%
Total Equity
$1.23B
Shares Out
172M
Business description

ACADIA PHARMACEUTICALS INC — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 17 → 1,072 +58.5% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022⚑FY2023FY2024FY2025
Revenue171252243394424845177269581,072
Cost of revenue(3)(9)(12)(11)(10)(11)(10)(42)(82)(89)
Gross profit14116211328432473507685——
Research & development(99)(149)(187)(240)(319)(239)(362)(352)(303)(329)
Selling, general & administrative(186)(255)(266)(326)(389)(396)(369)(407)(488)(549)
General & administrative——————————
Total operating expenses(290)(417)(471)(586)(728)(655)(741)(800)(727)(967)
Operating income(273)(292)(247)(247)(287)(170)(224)(73)231105
Other income (expense), net——(2)1(1)(2)4522
Pre-tax income(270)(288)(244)(234)(281)(168)(213)(51)258139
Income tax expense(1)(1)(1)(1)(1)0(3)(10)(32)(252)
Net income(271)(289)(245)(235)(282)(168)(216)(61)226391
EPS — basic———————($0.37)$1.37$2.32
EPS — diluted———————($0.37)$1.36$2.30
Shares outstanding — basic (M)————000164166168
Shares outstanding — diluted (M)————000164166170

Showing the latest 10 of 17 fiscal years.

  • ⚑ Weighted-average shares changed ×2.98 between FY2012 and FY2023 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.